Pesquisar
Envista Holdings Corp
NVSTAdicionar à lista de desejos
27.310USD
-0.460-1.66%
Fechamento 07-31 16:00（ET）Cotações atrasadas em 15 min
4.44BValor de mercado
66.37P/L TTM
Mais detalhes de Envista Holdings Corp Empresa
Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
Informações de Envista Holdings Corp
Código da empresaNVST
Nome da EmpresaEnvista Holdings Corp
Data de listagemSep 18, 2019
CEOKeel (Paul A)
Número de funcionários12300
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 18
Endereço200 S. Kraemer Blvd., Bldg. E
CidadeBREA
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal92821
Telefone17148175418
Sitehttps://envistaco.com/en
Código da empresaNVST
Data de listagemSep 18, 2019
CEOKeel (Paul A)
Executivos da empresa Envista Holdings Corp
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
154.81K
-8.28%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
62.36K
+11.90%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
56.88K
+9.83%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
49.49K
+18.85%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
49.48K
+18.86%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
43.56K
+21.42%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
42.49K
+21.96%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
11.75K
-381.11%
Mr. Mischa M. Reis
Mr. Mischa M. Reis
Senior Vice President - Strategy and Corporate Development
Senior Vice President - Strategy and Corporate Development
--
--
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
154.81K
-8.28%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
62.36K
+11.90%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
56.88K
+9.83%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
49.49K
+18.85%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
49.48K
+18.86%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
43.56K
+21.42%
Perguntas frequentes
Quem são os cinco principais acionistas de Envista Holdings Corp?
Os cinco principais acionistas de Envista Holdings Corp são: Mr. Paul A. Keel
Quantas instituições possuem ações da Envista Holdings Corp (NVST)?
Em 2026Q1, 711 instituições possuíam ações da Envista Holdings Corp, com valor de mercado aproximado de 203.45M, representando 125.03% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -3285874.00.